Document is current
Any future updates will be listed below
-
Authors
Kintscher, Ulrich
Edelmann, Frank
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 21 April 2023
Accepted: 22 June 2023
First Online: 29 June 2023
Declarations
:
: UK received research grants/ speaker honoraria from Bayer AG. UK received speaker honoraria from Amarin, Berlin Chemie, Novartis, Servier, Sanofi, and participated in advisory boards of Berlin Chemie, Boehringer Ingelheim, Novartis, Sanofi. FE reports personal fees and non-financial support from Novartis, grants and personal fees from Boehringer Ingelheim, personal fees from CVRx, Pfizer, Medtronic, grants and personal fees from Servier, personal fees from MSD/Bayer, personal fees from Bayer, personal fees from Resmed, personal fees from Berlin Chemie, grants from Thermo Fischer, personal fees from Vifor Pharma, personal fees from PharmaCosmos, personal fees from Merck , grants and personal fees from Astra Zeneca, outside the submitted work.
: Not applicable.
: All authors agree on the publication of the manuscript.
